glutamic acid has been researched along with Anochlesia in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 13 (52.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalinina, TS; Kiselev, AV; Sergienko, VI; Stovbun, IS; Vedenkin, AS | 1 |
| Funada, M; Takebayashi-Ohsawa, M | 1 |
| Melo-Thomas, L; Schwarting, R; Tonelli, LC; Wöhr, M | 1 |
| Antony, J; Choephel, T; Jeyarani, V; Jose, A; Kannan, E; Karolina Sahadevan, S; Manisha, C; Mannan Thodukayil, N; Thomas, P | 1 |
| Barbosa-Silva, RC; Medeiros, P; Melo-Thomas, L; Tonelli, LC; Viana, MB | 1 |
| Caron, MG; Chen, M; Dulman, RS; Jin, J; Park, SM; Rodriguiz, RM; Schmerberg, CM; Wetsel, WC | 1 |
| Blobaum, AL; Bubser, M; Conn, PJ; Daniels, JS; Engers, DW; Hopkins, CR; Javitch, JA; Jones, CK; Lin, X; Lindsley, CW; Loch, MT; Niswender, CM; Rodriguez, AL; Thompson Gray, A | 1 |
| Jain, R; Meena, CL; Pant, AB; Rajput, SK; Sharma, AK; Sharma, SS | 1 |
| Becker, A; Berek, I; Grecksch, G; Härtl, A; Höllt, V; Schröder, H | 1 |
| Binas, B; Fukunaga, K; Owada, Y; Shioda, N; Watanabe, M; Yamamoto, Y | 1 |
| Brandão, ML; Coimbra, NC; Ferrari, EA; Francisco, A; Maisonnette, SS; Medeiros, P; Mello, RO; Melo, LL; Santos, P | 1 |
| Parada, CA; Rondon, ES; Valadão, CA; Vieira, AS | 1 |
| Jardemark, K; Malmerfelt, A; Marcus, MM; Shahid, M; Svensson, TH | 1 |
| Amalric, M; Blobaum, AL; Bode, J; Bridges, TM; Bubser, M; Conn, PJ; Daniels, JS; Dickerson, JW; Engers, DW; Hopkins, CR; Italiano, K; Jadhav, S; Jones, CK; Lindsley, CW; Morrison, RD; Niswender, CM; Thompson, AD; Turle-Lorenzo, N | 1 |
| Blaudzun, H; Kaiser, N; Lemberger, T; Lutz, B; Marsicano, G; Massa, F; Monory, K; Schütz, G; Wotjak, CT | 1 |
| Egashira, N; Egawa, T; Fujiwara, M; Irie, K; Iwasaki, K; Katsurabayashi, S; Kitamura, Y; Koushi, E; Mishima, K; Nishimura, R; Orito, K; Sano, K; Takasaki, K; Uchida, N | 1 |
| Butterworth, RF; Landreville, F; Merkel, AD | 1 |
| Banerjee, SP; Lidsky, TI; Schneider, JS; Yablonsky-Alter, E; Zuck, LG | 1 |
| Gupta, MC; Singh, J | 1 |
| Kratzer, U; Kretschmer, BD; Schmidt, WJ | 1 |
| Kretschmer, BD; Schmidt, WJ; Tzschentke, TM | 1 |
| Awad, H; Bradley, SR; Conn, PJ; Levey, AI; Marino, MJ; Rouse, ST; Wittmann, M | 1 |
| Berchanski, A; Elazar, Z | 1 |
| Fukushima, R; Kizu, A; Miyagishi, T; Ono, T; Yoshida, Y | 1 |
| Close, SP; Elliott, PJ; Hayes, AG; Marriott, AS; Walsh, DM | 1 |
25 other study(ies) available for glutamic acid and Anochlesia
| Article | Year |
|---|---|
Calcium Salt of N-(5-Hydroxynicotinoyl)-L-Glutamic Acid Weakens Depressive-Like Behavior and Parkinsonian Syndrome in Experiment on Rodents.
Topics: Animals; Antidepressive Agents; Calcium; Catalepsy; Depression; Glutamic Acid; Haloperidol; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders | 2019 |
Synthetic cannabinoid AM2201 induces seizures: Involvement of cannabinoid CB
Topics: Animals; Catalepsy; Electroencephalography; Glutamic Acid; Hippocampus; Indoles; Male; Mice; Mice, Inbred ICR; Proto-Oncogene Proteins c-fos; Receptor, Cannabinoid, CB1; Seizures; Synaptic Transmission | 2018 |
Paradoxical kinesia induced by appetitive 50-kHz ultrasonic vocalizations in rats depends on glutamatergic mechanisms in the inferior colliculus.
Topics: Animals; Appetitive Behavior; Catalepsy; Diazepam; Disease Models, Animal; GABA Modulators; Glutamic Acid; Haloperidol; Inferior Colliculi; Male; N-Methylaspartate; Neurotransmitter Agents; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Ultrasonics; Vocalization, Animal | 2018 |
Desferrioxamine and dextromethorphan combination exhibited synergistic effect and reversed the catalepsy behaviour in 6-hydroxydopamine hydroydopamine administered rats through regulating brain glutamate levels.
Topics: Animals; Antioxidants; Catalepsy; Corpus Striatum; Deferoxamine; Dextromethorphan; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Drug Combinations; Drug Synergism; Glutamic Acid; Hydroxydopamines; Male; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Wistar | 2019 |
Glutamatergic neurotransmission in the inferior colliculus influences intrastriatal haloperidol-induced catalepsy.
Topics: Animals; Antipsychotic Agents; Catalepsy; Corpus Striatum; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Inferior Colliculi; Male; N-Methylaspartate; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2014 |
Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice.
Topics: Animals; Antipsychotic Agents; Arrestins; beta-Arrestins; Catalepsy; Disease Models, Animal; Dopamine Agents; Drug Evaluation, Preclinical; Female; Glutamic Acid; Male; Mice, 129 Strain; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Phencyclidine; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology; Social Behavior | 2016 |
Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.
Topics: Allosteric Regulation; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Brain; Catalepsy; Disease Models, Animal; Dopamine Agonists; Forelimb; Glutamic Acid; Haloperidol; HEK293 Cells; Humans; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Transfection | 2016 |
Effect of L-pGlu-(1-benzyl)-l-His-l-Pro-NH
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Ischemia; Catalepsy; Cell Death; Disease Models, Animal; Glucose; Glutamic Acid; Haloperidol; Hippocampus; Inflammation Mediators; Lipid Peroxidation; Male; Memory Disorders; Mice; Models, Biological; Motor Activity; Neurons; Oxygen; PC12 Cells; Rats; Scopolamine; Thyrotropin-Releasing Hormone | 2016 |
Ampullosporin A, a peptaibol from Sepedonium ampullosporum HKI-0053 with neuroleptic-like activity.
Topics: Animals; Antipsychotic Agents; Anxiety; Apomorphine; Avoidance Learning; Body Temperature; Brain; Catalepsy; Dizocilpine Maleate; Dopamine; Glutamic Acid; Hyperkinesis; Male; Motor Activity; Peptaibols; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Rotarod Performance Test; Social Behavior | 2009 |
Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain.
Topics: Acetylcholine; Animals; Brain Chemistry; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Catalepsy; Cell Line, Tumor; Dopamine; Extracellular Signal-Regulated MAP Kinases; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Glutamic Acid; Haloperidol; Humans; Immunohistochemistry; Interneurons; Ligands; Methamphetamine; Mice; Mice, Knockout; Neostriatum; Phosphorylation; Protein Binding; Receptors, Dopamine D2; Synaptic Transmission | 2010 |
Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy.
Topics: 2-Amino-5-phosphonovalerate; Animals; Catalepsy; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Inferior Colliculi; Male; Microinjections; Motor Activity; N-Methylaspartate; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Statistics, Nonparametric; Synaptic Transmission | 2010 |
The improvement of the anti-hyperalgesic effect of ketamine and of its isomers by the administration of ifenprodil.
Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Catalepsy; Dose-Response Relationship, Drug; Glutamic Acid; Glycine; Hyperalgesia; Injections, Spinal; Isomerism; Ketamine; Male; Motor Activity; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2010 |
Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Catalepsy; Drug Synergism; Glutamic Acid; Glycine Plasma Membrane Transport Proteins; Haloperidol; Male; Membrane Potentials; Olanzapine; Oxadiazoles; Piperidines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, AMPA; Risperidone; Synaptic Transmission; Tetrahydronaphthalenes | 2012 |
The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Brain; Calcium Signaling; Catalepsy; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Glutamic Acid; Haloperidol; HEK293 Cells; Humans; Levodopa; Male; Monoamine Oxidase; Motor Neuron Disease; Oxidopamine; Parkinson Disease; Picolinic Acids; Protein Binding; Psychomotor Performance; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reaction Time; Receptors, G-Protein-Coupled; Receptors, Metabotropic Glutamate; Substantia Nigra; Thallium; Transfection; Triazoles; Tyrosine 3-Monooxygenase | 2012 |
Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice.
Topics: Animals; Autonomic Nervous System; Behavior, Animal; Body Temperature; Catalepsy; Corpus Striatum; Dronabinol; gamma-Aminobutyric Acid; Gene Expression; Gene Silencing; Glutamic Acid; Interneurons; Male; Mice; Mice, Knockout; Motor Activity; Neocortex; Nociceptors; Pain Threshold; Psychotropic Drugs; Receptor, Cannabinoid, CB1 | 2007 |
Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
Topics: Acoustic Stimulation; Amantadine; Animals; Catalepsy; Dizocilpine Maleate; Dopamine Agents; Dronabinol; Excitatory Amino Acid Antagonists; Extracellular Space; Glutamic Acid; Hallucinogens; Male; Microinjections; Neurons; Nucleus Accumbens; Physical Stimulation; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Rimonabant; Serotonin; Serotonin Receptor Agonists; Synaptic Transmission | 2008 |
Regional amino acid distribution in relation to function in insulin hypoglycaemia.
Topics: Amino Acids; Animals; Aspartic Acid; Brain; Catalepsy; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glutamine; Humans; Hypoglycemia; Insulin; Male; Rats; Rats, Inbred Strains; Tissue Distribution | 1982 |
Taurine prevents haloperidol-induced changes in striatal neurochemistry and behavior.
Topics: Animals; Antipsychotic Agents; Catalepsy; Corpus Striatum; Drug Administration Schedule; Evaluation Studies as Topic; Glutamic Acid; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Taurine | 1995 |
Effect of aspartate and glutamate on nociception, catalepsy and core temperature in rats.
Topics: Adrenergic Uptake Inhibitors; Analgesia; Analgesics, Opioid; Animals; Aspartic Acid; Body Temperature; Catalepsy; Chlorpromazine; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fever; Glutamic Acid; Haloperidol; Hypothermia; Injections, Subcutaneous; Ketamine; Male; Morphine; Naloxone; Narcotic Antagonists; Nociceptors; Rats; Reserpine; Trifluoperazine | 1997 |
Riluzole, a glutamate release inhibitor, and motor behavior.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Behavior, Animal; Benzazepines; Benzodiazepines; Catalepsy; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Locomotion; Male; Motor Activity; N-Methylaspartate; Neuropsychological Tests; Postural Balance; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Riluzole; Smell | 1998 |
State-dependent blockade of haloperidol-induced sensitization of catalepsy by MK-801.
Topics: Animals; Antipsychotic Agents; Catalepsy; Central Nervous System Stimulants; Dizocilpine Maleate; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata.
Topics: Animals; Bridged Bicyclo Compounds; Catalepsy; Dopamine Antagonists; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Haloperidol; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Receptors, Presynaptic; Substantia Nigra; Subthalamic Nucleus | 2000 |
Glutamatergic-cholinergic synergistic interaction in the pontine reticular formation. Effects on catalepsy.
Topics: Animals; Carbachol; Catalepsy; Cholinergic Agonists; Drug Synergism; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Microinjections; Rats; Receptors, Cholinergic; Receptors, Glutamate; Reticular Formation | 2001 |
Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy.
Topics: Animals; Catalepsy; Cerebral Cortex; Corpus Striatum; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Haloperidol; Male; N-Methylaspartate; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Valine | 1991 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Fluphenazine; Glutamates; Glutamic Acid; Male; Microinjections; Parkinson Disease; Phencyclidine; Rats; Receptors, Glutamate; Receptors, Neurotransmitter; Sulpiride | 1990 |